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Abstract
Anxiety-related conditions are among the most difficult neuropsychiatric diseases to treat 
pharmacologically, but respond to cognitive therapies. There has therefore been interest in 
identifying relevant top-down pathways from cognitive control regions in medial prefrontal cortex 
(mPFC). Identification of such pathways could contribute to our understanding of the cognitive 
regulation of affect, and provide pathways for intervention. Previous studies have suggested that 
dorsal and ventral mPFC subregions exert opposing effects on fear, as do subregions of other 
structures. However, precise causal targets for top-down connections among these diverse 
possibilities have not been established. Here we show that the basomedial amygdala (BMA) 
represents the major target of ventral mPFC in amygdala in mice. Moreover, BMA neurons 
differentiate safe and aversive environments, and BMA activation decreases fear-related freezing 
and high-anxiety states. Lastly, we show that the ventral mPFC–BMA projection implements top-
down control of anxiety state and learned freezing, both at baseline and in stress-induced anxiety, 
defining a broadly relevant new top-down behavioural regulation pathway.
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Human1,2 and animal3,4 studies have implicated diverse cortical and subcortical regions in 
anxiety and fear regulation. Interestingly, altered structure1 and activity correlations2 
between mPFC and amygdala have been reported in patients with anxiety disorders, 
although the precise causal connections remain unclear3,5. Complexity is suspected, since 
ventral and dorsal mPFC (vmPFC and dmPFC, respectively) may have opposing roles in 
fear (vmPFC inhibits dmPFC6, and stimulation of vmPFC7 or dmPFC3 respectively 
decreases or increases freezing). Relevant subcortical regions are also complex; inhibitory 
intercalated cells (ITCs) in amygdala have been hypothesized to be vmPFC targets8, and to 
inhibit fear-promoting cells of the central nucleus of the amygdala, which could be relevant 
to the decreased freezing caused by electrical stimulation of vmPFC3. In contrast, dmPFC 
innervates the basolateral amygdala (BLA)9, and the bulk of the BLA population promotes 
fear10–12. This model could explain vmPFC–dmPFC functional differences3,10 and why 
lesioning ITCs promotes freezing13, but has never directly and precisely been tested.
In rats the vmPFC–ITC projection is sparse8, suggesting consideration of other targets of 
mPFC in amygdala for mediation of top-down control. Moreover, prior investigations of 
mPFC–amygdala circuitry employed electrical13–15 or optical stimulation that did not 
precisely resolve projections defined by cortical subregion origin and amygdala subregion 
target7,16,17. Finally, slower-timescale vmPFC18–21 and dmPFC18,22,23 lesions and 
inactivations have generated conflicting effects on anxiety. The precise identity of a 
functional top-down anxiolytic circuit has thus remained unknown. Here, we resolved 
distinct mPFC–amygdala projections in mice by combining anatomical tracing, CLARITY, 
in vivo and in vitro mapping of functional connectivity, and optogenetic control of mPFC–
amygdala projections during fear- and anxiety-related behaviours.
Direct top-down control of anxiety
Increased anxiety involves alterations in physiology and behaviour (for example, increases 
in respiratory rate and risk-avoidance)24. In rodents, avoidance of open arms of the elevated 
plus maze (EPM) is a measure of anxiety-related behaviour24,25. We expressed 
channelrhodopsin ChR2-H134R in mouse vmPFC (Extended Data Fig. 1a, b, Supplementary 
Note 1) and implanted fibre-optic cannulae above the amygdala (vmPFC–amygdala:ChR2 
mice, Fig. 1a) or above vmPFC (vmPFC:ChR2 mice). vmPFC–amygdala activation 
decreased avoidance of open spaces in EPM (two-way repeated measures analysis of 
variance (ANOVA), opsin × epoch interaction, F2,37 = 3.1, P = 0.04, post-hoc Wilcoxon 
rank-sum test P = 0.009; Fig. 1b, see Extended Data Table 1 for absolute values) and open 
field (Extended Data Fig. 2d). Projection-targeting appeared to resolve a distinct cell 
population, since directly exciting the entire vmPFC was not anxiolytic (Extended Data Fig. 
2b, c).
Respiratory rates increased during exploration of the anxiogenic open field (relative to home 
cage)24,26,27 in control animals (second and third epochs in Fig. 1c, g marked by a dashed 
red line, Fig. 1c; see Extended Data Fig. 3 for heart rate (a), sham-injected animals (e–h) and 
raw traces (i, j)). vmPFC–amygdala activation suppressed this increase in respiratory rate 
(Fig. 1c; two-way repeated measures ANOVA, main effect of opsin, F2,29 = 11.7, P = 
0.0014, post-hoc Wilcoxon rank-sum test, P = 0.03) without changing locomotion (Fig. 1d), 
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or respiratory rate in the home cage (Extended Data Fig. 3b), suggesting suppression of 
respiratory rate only in anxiogenic settings (Supplementary Note 2). Antidromic spikes in 
PFC were not readily detected following optogenetic excitation of vmPFC–amygdala: ChR2 
terminals (Extended Data Fig. 4). Dorsal mPFC (dmPFC) was investigated next. dmPFC–
amygdala: YFP mice did not exhibit labelled fibres in hypothalamus, in contrast to vmPFC–
amygdala: YFP mice (Extended Data Fig. 1c, g), supporting correct anatomical targeting9 
(Supplementary Note 1). Upon optical stimulation, dmPFC–amygdala: ChR2 mice showed 
no changes in behavioural (Fig. 1f, h and Extended Data Fig. 2g) or physiological (Fig. 1g 
and Extended Data Fig. 2h–j) measures of anxiety; consistent with prior reports28,29.
To evaluate the necessity of endogenous vmPFC–amygdala activity for anxiolysis, we 
expressed the inhibitory halorhodopsin eNpHR3.012,24 in vmPFC (Fig. 1i). vmPFC–
amygdala inhibition increased avoidance of open spaces in vmPFC–amygdala:eNpHR3.0 
mice in EPM (Fig. 1j; two-way repeated measures ANOVA, main effect of opsin × epoch 
interaction, F2,25 = 5.0, P = 0.014, post hoc Wilcoxon rank-sum test P = 0.02) and open 
field (Extended Data Fig. 2e). Moreover, vmPFC–amygdala inhibition in the home cage 
increased respiratory rate (Fig. 1k), but not locomotion (Fig. 1l) or heart rate (Extended Data 
Fig. 3d). Conversely, nonspecific mPFC inhibition did not change avoidance of open spaces 
(Fig. 1m, n and Extended Data Fig. 2f) or respiratory rate (Fig. 1o), revealing that vmPFC–
amygdala endogenous activity regulates anxiety states.
vmPFC–amygdala promotes fear extinction
To investigate if this top-down projection controlled fear-conditioning, we employed mild 
cued fear-conditioning to avoid ceiling effects on freezing. vmPFC–amygdala activation 
during extinction increased freezing in dmPFC–amygdala:ChR2 mice during extinction 
retrieval (Fig. 2a, P = 0.01, Wilcoxon rank-sum test). We next employed stronger cued fear-
conditioning to eliminate floor effects, allowing detection of freezing suppression. vmPFC–
amygdala activation enhanced cued fear extinction (two-way repeated-measures ANOVA, 
F18, 250 = 10.73, P = 0.0012 for group type) and extinction retrieval (P = 0.04, Wilcoxon 
rank sum test; Fig. 2b); increased extinction retrieval was also seen following stimulation of 
vmPFC somata (Extended Data Fig. 2a)7. vmPFC–amygdala activation also decreased 
freezing in contextual fear extinction and extinction retrieval (Fig. 2c, two-way repeated-
measures ANOVA; significant effect of group type, F2,29 = 8.7, P = 0.009). In contrast, 
dmPFC–amygdala activation did not alter contextual freezing (Fig. 2d, f).
Behavioural effects (Figs 1 and 2) were not attributable to activation of fibres-of-passage 
through amygdala, as vmPFC fibres were not observed in posterior sections of amygdala, 
revealing instead more proximal termination (Extended Data Fig. 5a, b); moreover, photo-
stimulation even 500 μ m posterior to the coordinates used in the above experiments did not 
modulate anxiety or freezing (Extended Data Fig. 5d, e). These data reveal the vmPFC–
amygdala projection suppresses fear-related freezing and high-anxiety states, while the 
dmPFC–amygdala projection selectively antagonizes only cued fear-extinction. Activation 
of either dmPFC or vmPFC projections to amygdala during cued fear acquisition did not 
alter freezing (Fig. 2g, h), in agreement with reports showing lack of mPFC involvement in 
fear acquisition30,31.
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BMA mediates vmPFC top-down control
We next sought precise circuit targets underlying this top-down modulation. We observed 
sparse vmPFC fibres in BLA and ITCs (Fig. 3b, c; CLARITY data, Supplementary Video 1; 
Extended Data Fig. 5c), but prominent investment of basomedial amygdala (BMA; Fig. 
3d)9,32,33. Conversely, dmPFC fibres strongly invested BLA (and ITCs, not previously 
reported), while sparing the BMA (Fig. 3e–g). Accordingly, vmPFC–amygdala activation 
induced c-Fos in BMA, but not in BLA or ITCs (Fig. 3h–l). We next injected the 
retrogradely propagating virus rabies-ΔG-GFP into BMA and identified a strong input 
specifically from vmPFC (Fig. 3m–o), predominantly from layer V (Extended Data Fig. 6a–
c); similar results were obtained with retrobeads (Extended Data Fig. 6d–h). Finally, we 
obtained whole-cell recordings from amygdala cells during optical stimulation of ChR2-
expressing mPFC terminals (in tetrodotoxin and 4-aminopyridine to abolish polysynaptic 
responses); stimulation of vmPFC terminals elicited monosynaptic responses in BMA (7/11 
cells), in contrast to BLA (1/8 cells) or ITCs (0/19 cells) (Fig. 4a–c). Conversely, dmPFC 
terminals spared BMA but elicited monosynaptic responses in BLA and the ventral ITC 
cluster (Fig. 4d–f).
We next found that BMA cells in vitro could follow 10 Hz stimulation of vmPFC fibres 
(Extended Data Fig. 7a), and that vmPFC–amygdala activation elicited initial BMA 
excitation followed by inhibition in vitro (Extended Data Fig. 7b) and in vivo (Extended 
Data Fig. 7c). The inhibition was probably mediated by directly recruited GAD2-expressing 
cells in BMA, since 91% of these receive vmPFC inputs (Extended Data Fig. 7g). Finally, 
we tested if specific activation of vmPFC cell bodies that project to BMA suppressed 
freezing. We targeted BMA-projecting vmPFC cells by injecting the retrogradely 
propagating canine adenovirus (CAV) encoding Cre-recombinase into BMA (Extended Data 
Fig. 8, Supplementary Note 3) and directing AAV-DIO-ChR2-YFP as well as optical fibres 
into mPFC (Fig. 5a, b). Activation of these cells decreased cued freezing during extinction 
and extinction retrieval (Fig. 5c), demonstrating that BMA can account for the behavioural 
effects seen following vmPFC–amygdala activation.
BMA inhibits fear and anxiety
If the BMA is naturally used to suppress fear and anxiety, then BMA spiking should 
differentiate safe and aversive contexts. We recorded BMA cells (Extended Data Fig. 9a, b) 
and used EPM scores to quantify arm-type encoding (Methods and refs 24,34). BMA 
neurons exhibited stable firing patterns (Extended Data Fig. 9c) with higher EPM scores 
than would be expected by chance (Fig. 5d, e; P = 0.01, Wilcoxon rank-sum test). In light–
dark tests (LDT), where anxiety is associated with the light compartment of the apparatus35; 
the same BMA cells showed similar changes in firing rate in EPM open arms and LDT light 
compartments (Extended Data Fig. 9d), indicating that BMA neurons encode anxiety-
associated contextual features. Among cells with positive EPM scores, neurons that fired 
preferentially in closed arms were over-represented (P < 0.05, binomial test) relative to 
open-arm-preferring cells (Fig. 5f). Similarly, a larger fraction of BMA cells (P < 0.01, 
binomial test) displayed inhibition versus excitation to fear-conditioned tones (Extended 
Data Fig. 9e). Consistent with this abundance of low-spiking BMA cells in actively 
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aversive/anxiogenic settings, and the hypothesized countervailing role for excitatory 
anxiolytic inputs to BMA, we found BMA activation (Fig. 5h, i) decreased avoidance of 
open arms (Fig. 5j; two-way repeated-measures ANOVA, main effect of opsin, F2,29 = 4.9, 
P = 0.03, post hoc Wilcoxon rank-sum test P = 0.04) and freezing in cued fear (Fig. 5k; two-
way repeated-measures ANOVA, main effect of opsin, F9,99 = 12.3, P = 0.004). Conversely, 
inhibition of BMA with eNpHR3.0 was anxiogenic in the open field (P < 0.05, main effect 
of opsin, two-way repeated-measures ANOVA, F2,25 = 4.1, P < 0.01, Fig. 5l), perhaps 
concordant with a role for the BMA in fear36,37.
Anxiolysis by the vmPFC–BMA circuit raised the possibility of top-down modulation of 
behaviour elicited by pathological conditions (such as high levels of corticosterone, since 
elevated cortisol-related stress hormones are known to be associated with anxiety 
disorders38–40). Indeed, chronic corticosterone treatment increased41,42 avoidance of open 
arms (Fig. 6a, P = 0.018, Wilcoxon rank-sum test), an effect reversed by vmPFC–amygdala 
activation (Fig. 6b).
Discussion
Here we identify the BMA as the direct target of vmPFC that suppresses fear-related 
freezing and anxiety states. Although these and other regions have been studied separately, a 
precise direct target for well-resolved vmPFC projections in top-down control of anxiety and 
fear had not been identified, nor had roles for the vmPFC–BMA projection been 
demonstrated. We find that this pathway is sufficient and necessary for anxiolysis; that cells 
inhibited by aversive stimuli are over-represented in BMA, and that BMA activity 
suppresses freezing and elevated-anxiety states. We also show the major source of prefrontal 
input to ITCs is not vmPFC, but rather dmPFC; for such circuit-level insight, precise 
projection-validated targeting of vmPFC versus dmPFC was crucial (Supplementary Note 
1).
While vmPFC-BMA activation suppressed freezing and elevated-anxiety states, neither bulk 
vmPFC activation (Extended Data Fig. 2a–c), nor control of other cortical (dmPFC) 
afferents to the target (amygdala; Fig. 1e–h), gave rise to similar effects. The lack of 
anxiolysis following direct vmPFC activation points to diversity in the vmPFC population, 
which probably includes cells that project to regions counteracting anxiolytic effects of 
vmPFC-BMA projections (Supplementary Note 4). Interestingly, inhibition of the vmPFC-
amygdala projection increased respiration but not heart rate, as seen in the bed nucleus of 
the stria terminalis (BNST)24, suggesting that heart rate may be regulated by other 
mechanisms perhaps related to direct sympathetic activation.
vmPFC also innervates the cortical and medial amygdala9; these structures may be activated 
in vmPFC-amygdala:ChR2 mice, and are not ruled out in regulating anxiolysis. 
Nevertheless, direct activation of BMA inhibits freezing. Interestingly, the BMA projects to 
several areas implicated in anxiolysis, such as the central lateral amygdala43, the vmPFC, 
and the BNST anterodorsal nucleus43, but not to directly adjacent anxiogenic regions, such 
as the dmPFC and the BNST oval nucleus (Extended Data Fig. 9k,l)24,43. Although freezing 
was not increased by direct optical inhibition of BMA cell bodies (Extended Data Fig. 9j), 
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pharmacological inhibition of the BMA increases freezing37, and its activation inhibits 
social stress-induced cardiovascular responses44.
The minimal vmPFC–ITC connectivity observed in mice (Figs 3c and 4c) does not conflict 
with studies in rats showing increased ITC activity following electrical45 or pharmacological 
vmPFC activation46, in which no direct projections were tested (such effects could be 
implemented through indirect routes such as via dmPFC, which we find directly projects to 
ITCs (Figs 3f and 4f). Influence of vmPFC on ITCs is not ruled out (despite the low 
functional47 and anatomical8 connectivity between these regions), and it remains possible 
that vmPFC–BMA and vmPFC–ITC influences could play complementary roles in 
regulating distinct fear or anxiety phenotypes. Diverse local direct target possibilities for 
mediating top-down control of fear have been hypothesized, including ITCs or BLA48; here 
we directly identify top-down control anatomy, as activation of BMA-projecting vmPFC 
neurons inhibits freezing (Fig. 5c).
A final intriguing aspect is that while direct BMA activation increased extinction, the 
extinction memory did not persist (Fig. 5k), whereas driving the vmPFC–BMA projection 
gave rise to stable extinction (Fig. 2b). Moreover, vmPFC–BMA stimulation only reduced 
freezing with several fear-conditioned tone presentations (Fig. 2b), suggesting that pairing 
cue exposure with vmPFC–BMA activity induces lasting plasticity. Such plasticity in 
vmPFC projections for lasting effects on fear memory is potentially relevant to therapeutic 
strategies and to natural anxiety and fear regulation.
METHODS
Subjects: mice
Male and female C57BL/6 mice were group-housed in a reverse 12 h light/dark cycle. Mice 
were 8 to 12 weeks old at the time of viral infusion. Food and water were given ad libitum. 
Dopamine receptor D1a (Drd1a)-Cre transgenic mice (EY266) were obtained from 
GENSAT. Ai9 lox-td Tomato mice were purchased from JAX (line 007902). All 
experimental protocols were approved by the Stanford University Institutional Animal Care 
and Use Committee and were in accordance with the guidelines from the National Institutes 
of Health. Sample sizes were chosen based on previous behavioural optogenetics studies on 
anxiety, which typically use 6–10 mice per group24. No statistical methods were used to 
predetermine sample size. Behavioural assays were conducted with male mice only, while 
both male and female mice were used for anatomical tracing and in vitro electrophysiology 
assays.
Subjects: rats
All data shown are from mice, except for Extended Data Fig. 5c, which shows data from 
rats. Wild-type male Sprague Dawley rats (250–400 g) were obtained from Charles River 
and were individually housed on a standard 12 h light/dark cycle and given food and water 
ad libitum.
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Viruses
All the adeno-associated virus (AAV) vectors used were serotyped with AAV5 coat proteins 
and packaged by the University of North Carolina Vector Core. All virus stock solutions 
were diluted to 2 × 1012 particles per ml. For ChR2 and YFP mice, 
AAV5:CamK2α:ChR2(H134R)-eYFP and AAV5:CamK2α:eYFP were infused, 
respectively. The CamK2α promoter was used to induce opsin expression preferentially in 
excitatory projection cells. AAV5-DIO-Ef1α -mCherry (used in the BMA of GAD2cre 
mice) and AAV5-DIO-Ef1α-ChR2(H134R)-YFP (used in vmPFC-amy:CAV-ChR2 mice) 
were injected at 8 × 1012 particles per ml. The maps for these viral vectors are available at 
http://www.optogenetics.org. Rabies-ΔG-GFP was provided by B. K. Lim and R. C. 
Malenka. CAV-Cre virus was obtained from The Institute of Molecular Genetics of 
Montpellie vector core (France), at 6.2 × 1012 particles per ml.
Surgery: mice
Eight-week-old mice were anaesthetized with 1.5–3.0% isoflurane and placed in a 
stereotaxic apparatus (Kopf Instruments). A scalpel was used to open an incision along the 
midline to expose the skull. After performing a craniotomy, 1.0 μl of AAV5-CamK2α-
ChR2(H134R)-YFP at a titre of 2 × 1012 particles per ml was injected per site (vmPFC or 
dmPFC) using a 10 μ l nanofill syringe (World Precision Instruments) at 0.1 μl min−1. The 
syringe was coupled to a 33 gauge bevelled needle, and the bevel was placed to face the 
anterior side of the animal. The syringe was slowly retracted 20 min after the start of the 
infusion. A slow infusion rate followed by 10 min of waiting before retracting the syringe is 
crucial to restrict viral expression to the vmPFC or dmPFC. Mice in vmPFC and dmPFC 
groups received unilateral viral infusion and fibre optic cannula implantation (0.22 NA, 200 
μm diameter; Doric Lenses) in either the vmPFC or the dmPFC. Infusion coordinates were: 
anteroposterior, 1.7 mm; mediolateral, 0.25 mm; dorsoventral, 3.3 mm for the vmPFC 
(injection centered in the dorsal peduncular cortex) and anteroposterior, + 1.9 mm; 
mediolateral, 0.25 mm; dorsoventral, 2.0 mm for the dmPFC. Fibre optic cannula 
implantation coordinates were: anteroposterior, 1.7 mm; mediolateral, 0.25 mm; 
drosoventral, 2.8 mm for the vmPFC and anteroposterior, +1.9 mm; mediolateral, 0.25 mm; 
dorsoventral, 1.5 mm for the dmPFC. For vmPFC–amygdala and dmPFC–amygdala mice, 
mPFC virus infusions were done bilaterally and fibreoptic cannulae were implanted 
bilaterally above amygdala (anteroposterior, −1.3 mm; mediolateral, 3.3 mm; dorsoventral, 
4.7 mm). All coordinates were measured from bregma.
Viral infusions targeting the vmPFC were centred in the dorsal peduncular cortex 
(Supplementary Note 1). These injections produced strong opsin expression in the 
peduncular cortex and the adjacent infralimbic cortex. On average, 61 ± 14% of vmPFC 
cells expressed YFP (data not shown). Viral infusions targeting the dmPFC were centred in 
the cingulate cortex. These injections produced strong opsin expression in the cingulate 
cortex and the adjacent prelimbic cortex. Only mice with opsin expression restricted to 
either the vmPFC or the dmPFC were used for behavioural assays. Mice with proper 
injections did not have a substantial number of YFP-expressing cell bodies outside the target 
region. However, fibres may be visible outside the target region, as the vmPFC and the 
dmPFC are reciprocally connected9. The boundary between dmPFC and vmPFC was 
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determined by comparing which coronal section in a reference brain atlas most closely 
corresponds to section being imaged. The boundaries were defined based on the position of 
easily identified structural landmarks, such as the forceps minor of the corpus callosum. 
Additionally, high magnification confocal imaging (20 ×) was used to evaluate if YFP-
expressing cell bodies was contained in a specific mPFC subregion. The projection patterns 
from dmPFC and vmPFC-injected mice also differed. Specifically, fibres from the vmPFC 
were seen in the dorsomedial and posterior nuclei of the hypothalamus, but not in the 
ventromedial hypothalamus. Fibres from the dmPFC were not found to innervate any part of 
the hypothalamus noticeably. This pattern of hypothalamic projections is in good agreement 
with prior anatomy studies comparing vmPFC and dmPFC projections9. Thus, mice injected 
in the vmPFC showed prominent fibres in the BMA and hypothalamus, but not in the BLA, 
while mice injected in the dmPFC had the complementary projection pattern. All mice 
included in the study had both YFP-expressing cell bodies confined to an mPFC subregion 
and the expected fibre projection pattern.
For mice expressing ChR2-YFP, NpHR-YFP or YFP in the BMA, 0.5 μl of AAV5-
CaMK2α∷ChR2(H134R)-YFP or AAV5-CaMK2α∷eNpHR3.0-YFP at a titre of 2 × 1012 
particles per ml was injected in the BMA (anteroposterior, − 1.3 mm; mediolateral, 2.8 mm; 
dorsoventral, 5.6 mm from bregma), and fibre optic cannulae were implanted 0.5 mm above 
the infusion site. Adhesive cement (C&B metabond) and dental cement (Stoelting) were 
used to securely attach the fibre optic cannulae to the skull. For experiments employing 
CAV-Cre, this virus was injected at 6.2 × 1012 particles per ml in the BMA (0.5 μl 
bilaterally). We also injected 1.0 μl bilaterally of AAV5-DIO-Ef1α-ChR2-YFP (8 × 1012 
particles per ml titre) in the vmPFC in these mice. For patch-clamping experiments using 
GAD2-Cre mice, we injected 1.0 μl of AAV5-Ef1α-mCherry (8 × 1012 particles per ml titre) 
in the BMA to label GAD2-expressing BMA interneurons. In these mice we also injected 
1.0 μl bilaterally of AAV5-CamK2α-ChR2-YFP (4 × 1012 particles per ml titre) in the 
vmPFC. Mice recovered from surgeries in a heated cage before returning to their home cage. 
Half the mice in each cage were randomly assigned to YFP or ChR2/NpHR groups.
Surgery: rats
Stereotactic surgeries were with rats (8–10 weeks of age) under isoflurane anaesthesia (4% 
initially, maintained at 2–3%). Respiratory rate and absence of the tail pinch response were 
monitored regularly. The scalp was shaved and rats were placed in the stereotax. A heating 
pad was used to prevent hypothermia. Lactated Ringer’s solution (5 ml kg−1 subcutaneous), 
buprenorphine (0.05 mg kg−1 subcutaneous) and enrofloxacin (5 mg kg−1, subcutaneous) 
were administrated to rats. A midline incision was made to expose the skull and a 
craniotomy was performed unilaterally over the mPFC Virus injections were delivered with 
a 10 μl syringe and 33 gauge bevelled needle injected at 100 nl min−1 using an injection 
pump. A single 1 μl injection (AAV5-CKIIα-SSFO-eYFP at a titre of 2–4 × 1012 particles 
per ml) was made at the following stereotactic coordinate to target the vmPFC (infralimbic 
cortex): anterioposterior, + 2.7 mm; mediolateral, 0.5 mm; dorsoventral, 5.0 mm from 
bregma. Following injection, the injection needle was kept at the injection site for 10 min 
then slowly withdrawn. The skin was sutured and the rats recovered in a clean cage under a 
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heated lamp. Rats were euthanized and perfused 5 months following surgery to allow strong 
YFP expression in vmPFC terminals in the amygdala.
Rabies tracing
For rabies tracing experiments, 1 μl of stock rabies-ΔG-GFP solution (provided by B. K. 
Lim and R. C. Malenka) was injected in the BMA (anterioposterior, − 1.3; mediolateral, 2.7; 
dorsoventral, 5.6). Mice were sacrificed 6 days following surgery. Brain slices were then 
obtained as described below in ‘Histology’. GFP-expressing cells were then counted on a 
Leica TCS SP5 scanning laser confocal microscope. Values plotted represent averages from 
12 brain slices (three slices from four different mice).
Retrobead tracing
Red retrobeads (LumaFluor) were injected undiluted using a 10 μl nanofill syringe (World 
Precision Instruments) at 0.1 μl min−1. The syringe was coupled to a 33 gauge bevelled 
needle, and the bevel was placed to face the anterior side of the animal. The syringe was 
slowly retracted 20 min after the start of the infusion.
Light delivery
For ChR2 mice, blue light was generated by a 473 nm laser (Omicron Laserage) at 10 mW 
power to stimulate fibres in the amygdala and at 1 mW to activate mPFC cell bodies. Yellow 
light was generated by a 593.5 nm DPSS laser (MGL-F593.5; OEM Laser Systems), and 
bilaterally delivered to mice at 10 mW. A Master-8 pulse generator (A.M.P.I.) was used to 
drive the laser at 10 Hz, with 5-milisecond pulses for the entire duration of the tone (20 s). 
The laser output was delivered to the animal via an optical fibre (200 μm core, 0.22 
numerical aperture, Doric Lenses), which was coupled to the fibre optic implanted on the 
animals through a zirconia sleeve.
Elevated plus maze (EPM) and open field testing
Experiments were performed 3 weeks after surgery for vmPFC:ChR2 and BMA:ChR2 
groups and 3 months after surgery for vmPFC-amy:ChR2, vmPFC-amy:NpHR and dmPFC-
amy:ChR2 groups, to allow for sufficient opsin expression. Mice were handled for 3 days 
before behavioural testing. On the day of the experiment, the fibre optic cannulae implanted 
on animals were connected to a patch cord. The animal was allowed to recover from this 
handling for 1–5 min in a cage before behavioural testing. The elevated plus maze was made 
of plastic painted grey (Med Associates), and the open field was a custom-made box with 
white plastic walls (dimensions: 50 × 50 × 50 cm). In the beginning of the test mice were 
gently placed in the periphery of the open field or the closed arms of the EPM. The EPM 
and open field sessions lasted 15 and 20 min, respectively. The only exception is for the 
experiment with corticosterone-treated mice, which explored the EPM for only 5 min. For 
both paradigms the session was divided into blocks of 5 min, which started with an ‘off’ 
epoch and then alternated between ‘off’ and ‘on’ epochs. Laser light was delivered for 5-min 
during ‘on’ epochs only. Both opsin and YFP-expressing animals that spent less than 5% 
time exploring the open arms of the EPM or centre of the open field were excluded from 
assays in which the optogenetic manipulation was expected to increase anxiety, as these 
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animals already had ceiling levels of anxiety at baseline. This exclusion criterion was pre-
established before the start of the experiment. In the experiment in which mice were treated 
chronically with corticosterone, mice ran the EPM for only 5 min, and blue light was 
delivered during the entire session to all groups of mice as 10-Hz trains of 5-ms pulses. For 
all anxiety assays animal position tracking, behavioural scoring and velocity measurements 
were done by the Biobserve software automatically. All plots showing overall velocity were 
from open field exploration sessions. The experimenter was blind to the opsin group of the 
animal while running the experiment.
Chronic treatment with corticosterone
Mice were anaesthetized with 1.5–3.0% isoflurane and a small incision was made on the 
side of the neck. Corticosterone or placebo pellets (#G-111, Innovative Research of 
America) were placed in the neck incision, and were positioned between the skin and the 
underlying muscle tissue. Behavioural experiments were performed 15 days following 
implantation of the pellets. We tested pellets containing 7.5 and 15 mg of corticosterone, 
which are active over 21 days. For a 30 g mouse these pellets correspond to doses of 12.5 
and 25 mg kg−1 corticosterone per day. The pellets are made of a biodegradable matrix of 
cholesterol and cellulose, and allow for constant release of corticosterone.
Fear conditioning
All mice were handled for three days before behavioural assays for 5 min per day. The 
pulse-generator driving the laser was synchronized to tone onset by coupling the laser pulse-
generator to the tone with a TTL pulse originating from the fear conditioning software 
(Freeze Frame, Actimetrics). For cued fear conditioning experiments, mice were placed in a 
chamber with a grid floor connected to a shock generator (Coulbourn). Two minutes after 
being placed in the chamber, mice were exposed to 20-s tones (2.9 kHz, 85 dB) co-
terminating with a foot shock at pseudo-random inter-trial intervals (~2 min average). The 
protocol in Fig. 2b used six tone-shock pairings (0.7 mA, 2-s shocks), and the experiments 
in Fig. 2a used four tone-shock pairings (0.4 mA, 1-s shocks). The chamber was cleaned 
with 70% ethanol at the end of each trial. The next day (day 2, fear extinction), mice were 
placed in a different context (floor and walls were changed and white vinegar was sprayed in 
the chamber). First, mice were exposed to one tone without light delivery, to measure fear 
retrieval (tone 1 on day 2). Subsequently, mice were exposed to 10 tones (tones 2–11 on day 
2) to undergo fear extinction with paired blue light delivery (10 Hz train of 5-ms pulses for 
20 s). On day 3 mice were placed in the same environment as in day 2 and were exposed to 
one presentation of the tone. For the strong contextual fear conditioning protocol shown in 
Fig. 2c, d, mice explored the fear conditioning chamber for 2 min. Subsequently, mice 
received five 1-s foot shocks (0.4 mA) with ~2 min intervals on day 1. On day 2 blue light 
was delivered bilaterally to the amygdala while mice explored the same environment and on 
day 3 mice were tested for extinction retrieval in the same environment. The mouse explored 
the environment for 5 min during days 2 and 3. The weaker contextual conditioning protocol 
shown in Fig. 2e, f was similar, except that mice were conditioned to three 0.4 mA 1-s 
shocks and exposed to the training environment for 20 min on day 2 with blue light 
delivered for the entire 20 min. The experimenter was blind to the opsin group of the animal 
while running the experiment.
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Respiratory and heart rate measurements
Respiratory rate and heart rate were measured using a pulse oximeter (MouseOx Plus; Starr 
Life Sciences). Pulse oximetry works by placing a collar clip around the mouse’s shaved 
neck. One side of the collar emits red and infrared light, which pass through the neck and is 
measured on the other side of the neck by a detector. Oxygen-bound haemoglobin and de-
oxygenated haemoglobin respectively absorb the infrared and red light preferentially. The 
ratio of these absorbances can be used to calculate oxygen saturation. Additionally, the small 
dilations in blood vessels induced by heart beats and respiration can also be detected by the 
change in the absorbances of these wavelengths. The functioning and limitations of this 
technique have been described in detail elsewhere49.
Data was collected on a computer running MouseOx Plus software. Mice were shaved 
around the neck and acclimated to moving with the collar sensor used to by the pulse 
oximeter for three days. Additionally, mice were handled for three days before 
experimenting. Respiratory rate was recorded as a moving average of ten measurements 
recorded at 1 Hz. Heart rate was recorded as a moving average of five heart beats. Baseline 
respiratory rate was typically in the 160 to 230 breaths per min range, while heart rate was in 
the 690 to 790 beats per min range. The MouseOx Plus software generates errors during 
abrupt movements made by the animal, as these motion artefacts generate unreliable 
readings. Only error-free data was used from sessions in which the recordings had at least 
30% of error-free samples. Recordings were obtained for either 15 min only in the home 
cage or for 5 min in the home cage and 10 min in the open field. The experimenter was blind 
to the opsin group of the animal while running the experiment.
Microdrive construction and implantation
Microdrives were custom built using Neuralynx (Neuralynx) a 16-channel electronic 
interface board (EIB-16), as described elsewhere34. Stereotrodes were made with 25-μm 
Formvar-coated tungsten microwires (M165260, California Fine Wires) and were inserted 
into a metal cannula (GHX-24, Component Supply Co.), which in turn was attached to the 
‘R’ channel slot of the EIB-16. A fibre optic cannula was glued to the outer part of the metal 
cannula, and glued to the protruding shaft of the stereotrode bundle, with care being taken 
not to glue the electrode tips. The stereotrodes were cut so that they extended 0.5 mm 
beyond than the end of the tip of the fibre optic. This design allows for light delivered 
through the cannula to reach the cells recorded by the stereotrode tips without having the 
fibre optic damage the cells being recorded. The EIB-16 was secured with screws 
(SHCX-080-6; Small Parts) to a custom-built teflon platform. The platform and the EIB 
were in turn secured to teflon cuffs with screws, allowing the assembly containing the 
stereotrodes, EIB and fibre optic to be lowered by turning the screws after the teflon cuffs 
have been cemented to the animal’s skull as described previously34. Before steretactically 
implanting the microdrive, one screw was placed in the front of the skull to increase the 
cemented (Grip Dental Cement; Dentsply) assembly’s physical stability. Another screw was 
placed over the cerebellum to serve as an electrical ground and was soldered to the ground 
slot in the EIB (slot labelled ‘G’).
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In vivo electrophysiology data acquisition
Recordings were performed as described previously34. Mice recuperated from the 
implantation of the microdrive for one week. Animals were then handled for three days and 
habituated to moving with the tether connecting the microdrive to the recording system. 
Stereotrodes were advanced until at least four well-isolated single units were present. Mice 
were then placed in the EPM for 15 min. Recordings were made with a unity-gain head-
stage preamplifier (HS-16, Neuralynx) coupled to a fine-wire cable. Spikes larger than 25 
μV were band-pass filtered (600–6,000 Hz) and recorded at 32 kHz. Neural data were 
acquired on a personal computer running Neuralynx Cheetah software.
Animal position was tracked at 30 Hz using an overhead camera that detected two small 
LEDs attached to the head-stage. In experiments that used blue light to activate vmPFC 
terminals in the amygdala, the output of the laser pulse generator was recorded along with 
local spiking activity by the same recording amplifiers, allowing synchronous acquisition of 
neural data and laser onset and offset times. Blue light was delivered using the same 
parameters employed in other behavioural assays described above (10-Hz trains of 5-ms 
pulses at 10 mW power). At the end of the experiment current was passed through one of the 
stereotrode channels to produce an electrical lesion in the site of recording. Recordings were 
performed for 35 min. During minutes 0 to 5 recordings were obtained in the home cage. 
From minutes 5 to 25 the animal explored the elevated plus maze (EPM). Lastly, during 
minutes 25 to 35 the animal explored the light/dark test (LDT).
Antidromic spike recording
Mice expressing ChR2 in vmPFC cell bodies (injections as for behaviour) were 
anaesthetized using 1–2% isoflurane. Stimulation light pulses were delivered to the BMA 
using the same optical fibre type, coordinates, and stimulation pulse parameters as in 
behavioural experiments (5-ms pulses at 10 Hz). We used higher light power (80 mW) to 
maximize the chance of antidromic activation. Multiunit activity was simultaneously 
recorded across 32 in 2 animals (total 64 sites) spanning the entire mPFC (mediolateral, 0.4 
mm; anteroposterior, 1.6 mm; dorsoventral, 1.8–3.3 mm from bregma) using a silicon probe 
(A1x32-6mm-50-177-Z32, NeuroNexus). Signals from each recording site were amplified, 
digitized and digitally filtered (600–6,000 Hz) using a multichannel recording system 
(RZ5D, Tucker-Davis Technologies). Multiunit firing was assessed by thresholding raw 
traces at three standard deviations from baseline using custom analysis software (MATLAB, 
Mathworks). As a positive control, the stimulation optical fibre was retargeted to the 
recording location in mPFC using an angled approach to directly elicit local spiking.
Analysis of neural data
Code availability—All custom-written MATLAB code is available upon request.
Elevated plus maze—Following recording, single units were clustered manually offline 
with the SpikeSort3D software (Neuralynx). Data were then imported into MATLAB using 
custom-written scripts. Peri-stimulus time histograms (PSTHs) of spiking activity were 
constructed for a 100 ms time window centred at the onset of 5-ms laser pulses. EPM scores 
were computed for all recorded single units to estimate the extent to which each unit 
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encoded arm type in the EPM24,34. The calculation of EPM scores has been explained in 
great detail in step-by-step fashion previously24. In brief fold-firing rates relative to the 
unit’s mean firing rate were calculated for each of the EPM’s compartments, and the score 
was computed by the formula
FL, FR, FU and FD are the fold-firing rate in left, right, up and down arms, respectively. For 
example, if the mean firing rate in the whole maze is 4 Hz, and the unit fired at 8 Hz in the 
left arm, then FL = 8/4 = 2. Left and right arms are closed arms, and up and down arms are 
open arms.
‘A’ is the mean difference in normalized firing rate between arms of different types, while 
‘B’ is the mean difference for arms of the same type. The maximum score of 1 indicates that 
all differences in firing between different arms can be explained by arm type (B = 0, where a 
unit has identical high rates only closed arms or only in open arms). A high EPM score 
indicates that a unit fires preferentially either in both closed arms or in both open arms. A 
score of zero indicates that a single unit has the same firing rate in all compartments of the 
EPM. A negative score would be assigned to a single unit that has similar firing rates in 
arms of different types (for example, a unit has high rates in one of the open arms and one of 
the closed arms).
Cells with EPM scores equal or smaller than zero were classified as not task-related. The 
remaining cells (all of which have EPM scores > 0) were classified as either closed- or open-
arm-preferring, if the cell displayed higher rates in the closed or open arms, respectively.
To calculate if the population of experimentally observed EPM scores was significantly 
different than expected by chance, a simulated distribution of scores was generated. For each 
unit with n spikes, 500 simulated scores were generated by calculating the EPM score of n 
randomly chosen timestamps 500 times. This artificially generated population of EPM 
scores was then compared to the scores obtained from actual BMA single units using 
Wilcoxon’s Rank sum test.
In order to analyse the stability of firing patterns of BMA cells in the EPM we calculated 
firing rates in the closed and open arms for the first and second halves of the EPM 
exploration session separately. We only used data from cells that fired at least 10 spikes in 
each arm type in each of the two halves of the session. EPM scores and preference of firing 
in a specific arm type were not significantly correlated with action potential waveform 
features that are commonly used to classify cells as excitatory or inhibitory (Supplementary 
Note 5).
Cued fear conditioning—Cells were classified as tone responsive if their firing rate 
during the tone presentation period was significantly different (P < 0.05 with the Wilcoxon 
rank sum test) from firing during baseline (the 40 s preceding the tone presentation).
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In vitro electrophysiology
Three months after injections, acute 300-μm coronal slices were prepared by transcardially 
perfusing the mice with an ice-cold sucrose solution (containing in mM: 125 NaCl, 2.5 KCl, 
0.1 CaCl2, 3.9 MgCl2, 26 NaHCO3, 1.25 NaH2PO4-H2O, 2.5 glucose, 50 sucrose) and 
slicing the brain tissue in the same ice-cold sucrose solution using a vibratome (VT1200S, 
Leica). Slices containing the PFC were fixed in 4% paraformaldehyde and saved for 
verification of the ChR2 injection site. Slices containing the amygdala were allowed to 
recover for 1 h at 33 °C in artificial cerebrospinal fluid (aCSF; containing in mM: 125 NaCl, 
2.5 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.25 NaH2PO4-H2O, 11 glucose) bubbled with 
95%O2/5%CO2. Whole-cell patch-clamp recordings were performed in the same aCSF 
solution at 30–32 °C. Where indicated, TTX (1 μm) and 4-AP (100 μM) were added to the 
aCSF. Resistance of the patch pipettes was 2.5–4 MΩ when filled with intracellular solution 
containing the following (in mM): 120 CsMeSO3,15 CsCl, 8 NaCl, 0.2 EGTA, 10 HEPES, 2 
Mg-ATP, 0.3 Na-GTP, 10 TEA (tetraethylammonium), 5 QX-314 (lidocaine N-ethyl 
bromide), adjusted to pH 7.25 with CsOH. In some experiments, 0.2% biocytin was also 
included in the intracellular solution. Slices containing biocytin-filled cells were later 
processed as explained in ‘Immunocytochemistry Biocytin’, to allow accurate visualization 
of the recorded cell’s location. Signals were amplified with a Multiclamp 700B amplifier, 
acquired using a Digidata 1440A digitizer, sampled at 10 kHz, and filtered at 2 kHz. All data 
acquisition and analysis were performed using pCLAMP software (Molecular Devices). 
Neurons were visually identified for patching using an upright microscope (Olympus 
BX51WI) equipped with DIC optics, filter sets for visualizing YFP and tdTomato, and a 
CCD camera (RoleraXR, Q-Imaging). After break-in, neurons were voltage-clamped at − 65 
mV. As neurons were recorded, pictures of the placement of the recording electrode were 
taken under low magnification (5 × /0.15 air objective) and the location of the recording was 
noted on a schematic of the amygdala. To stimulate ChR2 expressed in axon terminals from 
the PFC, 5-ms blue light pulses (~10 mW mm−2) were generated using a Spectra X LED 
light engine (Lumencor) and delivered to the slice via a 40 ×/0.8 water-immersion objective 
focused onto the recorded neuron. Pulses were delivered once every 30 s. Reponses sizes 
were calculated by baseline- subtracting and averaging 5–15 traces together, then calculating 
the peak amplitude in a 50 ms window after the light pulse. Neurons that did not show a 
peak amplitude in this window that exceeded 5 s.d. of the baseline noise were counted as 
non-responders. Recordings shown in Fig. 4 were performed in mice injected with 1 μl of 2 
× 1012 titre AAV5-K2α CamK2α -ChR2-YFP virus, similar to the infusions done in 
vmPFC–amygdala:ChR2 mice. Infusions done in GAD2-Cre mice were done with 4 × 1012 
titre (Extended Data Fig. 7g). This difference is probably why a higher fraction of BMA 
neurons were responsive to optical stimulation of vmPFC terminal in the latter experiment 
(91%) compared to Fig. 4 (63%). Importantly, cells from all three amygdala regions studied 
(BMA, BLA and ITC) were recorded from each mouse. This approach ensures that the 
unresponsiveness of ITC and BLA cells in mice expressing ChR2 in the vmPFC is not due 
to insufficient opsin expression or any other technical problem, as responsive BMA cells 
were recorded from the same animal.
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Histology
Mice were deeply anaesthetized and transcardially perfused with ice-cold 4% 
paraformaldehyde in PBS. Brains were fixed overnight in 4% paraformaldehyde and then 
equilibrated in 30% sucrose in PBS. Brains were sliced in 40-μm-thick coronal slices in a 
freezing microtome, and stored in cryoprotectant solution (a mixture of 5:6:9 volumes of 
glycerol, ethylene glycol and PBS) at 4 °C until being mounted on slides on PVA-DABCO. 
Nuclei were stained by incubating with DAPI (1:50,000 in PBS, 25 min). In animals with 
retrobead injections brain sections were stored in PBS at 4 °C in Fluoromount-G (Southern 
Biotech). Confocal images were obtained on a Leica TCS SP5 scanning laser microscope 
using a 20 ×/0.70 numerical aperture oil immersion objective. Only mice with opsin 
expression restricted to the target region and correct fibre optic cannula placement were 
used.
Immunocytochemistry and c-Fos counting: c-Fos
vmPFC–amygdala: ChR2 mice received blue light in the amygdala (10 Hz, 5-ms pulses, 10 
mW power) for 10 min. Animals were perfused 90 min after receiving optical stimulation. 
Following perfusion, brain slices were obtained as described above in ‘Histology’. c-Fos 
staining was performed as described previously46. In brief, coronal sections containing the 
amygdala were washed in PBS (three 10-min washes), and were then incubated for 1 h in 
blocking solution with 0.2% Triton-X-100 and 2% normal donkey serum. Sections were 
then incubated overnight with anti c-Fos primary antibody (rabbit anti c-Fos 1:500, Cell 
Signaling Technology, cat. no. 2250S). The next day the sections were washed in PBS (three 
10-min washes) and incubated at 1 h at room temperature with the secondary antibody at 
1:500 dilution (donkey anti-rabbit antibody conjugated to Cy3, Jackson Laboratories). Slices 
were washed three times in PBS and mounted on slides with PVA-Dabco (Sigma). c-Fos 
counting was performed blinded to treatment group on a Leica TCS SP5 scanning laser 
confocal microscope. To stain cells against GABA the same procedure was employed, but 
this time using anti-GABA antibody (Sigma, cat. no. A2052).
Immunocytochemistry and c-Fos counting: FoxP2
Staining against FoxP2 was done similarly to the procedure described above for c-Fos, but 
with the alterations described below. The first incubation was in 0.3% Triton-X in 3% 
normal donkey serum, and it lasted 2 h. The primary antibody used was anti-FoxP2 made in 
Rabbit (AbCam, cat. no.16046) at 1:500 dilution for 12 h at 4 °C. The secondary antibody 
was anti-rabbit conjugated to Alexa Fluor 647 (AbCam, cat. no. 150075), incubated at 1:500 
dilution for 3 h at room temperature.
Immunocytochemistry and c-Fos counting: GABA
Same procedure as FoxP2 staining, except that anti-GABA antibody was used (Sigma, cat. 
no. A2052), with 0.1% Triton-X.
Immunocytochemistry and c-Fos counting: biocytin
The same procedure used to stain against c-Fos was employed to visualize cells filled with 
biocytin during patch clamping recordings, with the following modifications. The first 
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incubation was in 0.3% Triton-X, and 3% normal donkey serum, and it lasted for 2 h. 
Instead of an incubation with a secondary antibody sections were incubated with 
streptavidin conjugated to Alexa Fluor 647 (5 μg ml−1) for 2 h at room temperature.
CLARITY
Slices from vmPFC-amygdala:YFP mice were clarified using the CLARITY procedure as 
explained elsewhere50. In brief, after patching, 300-μm sections were fixed in hydrogel 
solution (4% PFA, 1% acrylamide w/Bis) for 20 h at 4 °C. After polymerization (37 °C, 4 
h), the sections were clarified in 4% SDS for 2 days (at 37 °C). The cleared sections were 
washed three times with PBST (0.1% TritonX) for a total of 4 h at room temperature. 
Alexa647-conjugated anti-GFP antibody (1:100, Invitrogen) was used to stain YFP (room 
temperature, overnight). Stained sections were incubated in FocusClear (CelExplorer Labs 
Co.) for 1 h before imaging with a confocal microscope.
Statistics
Two-way repeated measures ANOVA was used. Wilcoxon rank sum post hoc tests were 
used following the ANOVA only if significant main or interaction effects were detected. 
Two-tailed tests were used throughout with α = 0.05. The Wilcoxon test is non-parametric, 
and as such it does not require the data to be normally distributed. Nevertheless, we tested 
the normality of all the behavioural data being used with the Lilliefors test, and found that 
our behavioural data passed this test. The variances of the groups being compared were not 
significantly different in any of the comparisons. Variance equality was tested using the F-
test. Asterisks in the figures indicate the P values for the post hoc test at a given epoch. 
Standard error of the mean (s.e.m.) was plotted in each figure as an estimate of variation 
within each group of data. Multiple comparisons were adjusted with the false discovery rate 
method. Our experimental design of having light stimulation ‘on’ and ‘off’ epochs in a 
single session for each animal allows us to use repeated measures ANOVA to test if light 
delivery significantly alters the behaviour of interest relative to its own baseline (that is, the 
first light off epoch). This strategy is statistically more powerful than comparing YFP and 
ChR2 groups with an unpaired test. As this statistical test evaluates changes relative to 
baseline, we opted to plot normalized data. In this way the data presentation accurately 
represents the differences that are being statistically tested. Importantly, there were no 
significant differences at baseline between YFP and experimental groups in behavioural or 
physiological measures of anxiety. In all figure legends n refers to biological replicates.
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Extended Data
Extended Data Figure 1. Methodology necessary for targeting viral infusions restricted to 
vmPFC and dmPFC
a, Scheme showing subregions of the mPFC. b, Representative example from one mouse 
showing a coronal section containing the vmPFC (IL+ DP) in a mouse expressing YFP in 
the vmPFC. c, d, Coronal section depicting vmPFC fibres in the hypothalamus (c) and 
amygdala (d). n = example from 1 mouse chosen from n = 7 mice (a–d). e–h, Same as a–d, 
but for an animal that received viral injection in the dmPFC (PL and Cg). n = example from 
1 mouse chosen from n = 7 mice (e–h). c, g, Note the presence of fibres from the vmPFC, 
but not dmPFC, in the hypothalamus. Specifically, the vmPFC projects strongly to the 
dorsomedial, but not ventromedial hypothalamus (DMH and VMH, respectively). g, Section 
showing expression of YFP in a vmPFC:YFP mouse. n = example from 1 mouse chosen 
from n = 7 mice. Cg, cingulate cortex; PL, prelimbic cortex; IL, infralimbic cortex; D P, 
dorsal peduncular cortex. Scale bars, 1 mm (b, f); 100 μm (c, g); 500 μm (d, h); 35 μm (i).
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Extended Data Figure 2. Optogenetic manipulations involving the mPFC and its projections to 
the amygdala in fear and anxiety paradigms
a, Mice were fear conditioned to six tone-shock (0.7 mA, 2-s shocks) pairings on day 1 (fear 
acquisition). On day 2 (fear extinction) animals were exposed to the tone in a different 
context for 11 trials. Blue light was delivered only on day 2, for trials 2–11. vmPFC:ChR2 
mice froze less than control mice during day 3 (extinction retrieval). b, c, Blue light delivery 
did not change avoidance of open spaces in vmPFC:ChR2 mice relative to control mice in 
the open field (b) or the EPM (c). n = 7 vmPFC:ChR2 and 7 vmPFC:YFP mice (a–c). d, 
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Excitation of the vmPFC–amygdala projection with blue light increased exploration of the 
centre of the open field in vmPFC–amygdala:ChR2 mice relative to controls. Two-way 
repeated measures ANOVA, opsin × epoch interaction, F3,68 = 3.1, P = 0.03, post hoc 
Wilcoxon rank sum test P = 0.002. n = 12 vmPFC–amygdala:ChR2 and 13 vmPFC–
amygdala:YFP mice. e, Inhibition of the same projection in vmPFC–amygdala:NpHR mice 
with yellow light increased avoidance of open spaces. Two-way repeated-measures 
ANOVA, main effect of opsin, F3,68 = 7.26, P = 0.008, post-hoc Wilcoxon rank sum test P 
= 0.03. n = 14 vmPFC–amygdala:NpHR and 11 vmPFC–amygdalal:YFP mice. f, Same as e, 
but for inhibition of vmPFC cell bodies. n = 11 vmPFC:NpHR and 8 vmPFC:YFP mice. g–j, 
Optogenetic stimulation of the dmPFC–amygdala projection did not alter behaviour in the 
open field (g), heart rate in the open field (h), heart rate in the home cage (i), or respiration 
rates in the home cage (j). Blue light stimulation epochs are labelled ON and/or with a blue 
bar. n = 7 dmPFC–amygdala:YFP and 7 mPFC–amygdala:ChR2 mice. b–j, Data are plotted 
in 5-min consecutive intervals. Light delivery epochs are labelled ON and/or with a blue or 
yellow bar. *P < 0.05, Wilcoxon rank sum test; error bars, ± s.e.m.; n refers to biological 
replicates.
Extended Data Figure 3. Heart and respiratory rate changes elicited by optogenetic 
manipulation of vmPFC fibres in the amygdala
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a, b, Optogenetic stimulation of vmPFC fibres in the amygdala in the home cage did not 
significantly alter heart (a) or respiratory rate (b) in mice in the home cage during the light 
ON period. Nevertheless, a downward trend was observed for both measurements during 
delivery of blue light. n = 12 vmPFC–amygdala:ChR2 and 6 vmPFC–amygdala:YFP mice. 
c, Blue light delivery in vmPFC–amygdala:ChR2, but not control, mice prevented increases 
in heart rate in the open field test (OFT) relative to the home cage. Two-way repeated 
measures ANOVA, main effect of opsin, F2,29 = 10.98, P = 0.0019, post-hoc Wilcoxon rank 
sum test P = 0.04; n = 11 vmPFC–amygdala:ChR2 and 6 vmPFC–amygdala:YFP mice. d, 
Inhibition of the vmPFC–amygdala projection in vmPFC–amygdala:NpHR mice with 
yellow light in the home cage did not alter heart rate. n = 6 vmPFC–amygdala:NpHR; 6 
vmPFC–amygdala:YFP mice. e–h, Mice were injected with saline in the vmPFC. Fibre 
optics were placed above the BMA. e, f, Delivery of blue light did not alter respiratory rate 
(e) or heart rate (f) in the home cage. g, h, Respiratory rate (g) and heart rate (h) increased, 
relative to the home cage, when mice were placed in the anxiogenic open field. Blue light 
delivery did not prevent the increase in respiratory and heart rate observed in the open field. 
n = 7 sham mice. a–h, Data are plotted in 5-min consecutive intervals. Light stimulation 
epochs are labelled with ON and with a blue or yellow bar. i, j, Example raw traces of 
respiratory (i) and heart rate (j) recorded at 1 Hz obtained from a freely moving mouse 
through pulse oximetry. Movement bouts are shown in green, and single samples with errors 
due to motion artefacts are shown as red crosses. Error samples are detected automatically 
by software (Starr Life Sciences). i, Most error samples occur during movement bouts and a 
few errors can be seen outside of movement bouts in the respiratory rate trace. j, Heart rate 
recordings are generally stable and errors occur only during prolonged and large movement 
bouts. Samples with errors were not used in any other plot or data analysis. Representative 
traces from one mouse. Error bars, ± s.e.m.; n refers to biological replicates.
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Extended Data Figure 4. Stimulation of ChR2-expressing vmPFC terminals in the basomedial 
amygdala: lack of detection of antidromic spikes in vmPFC
a, Mice were injected with AAV5-CamK2α -ChR2-YFP in the vmPFC. Blue light was 
delivered above the vmPFC. Simultaneous in vivo anaesthetized recordings under isoflurane 
were obtained from the vmPFC. b, Average of 64 recording sites in the mPFC showing that 
blue light elicited orthodromic spikes in ChR2-expressing cortical cells. c, Same as a, but 
blue light was delivered to ChR2-expressing vmPFC terminals in the BMA while recordings 
were obtained from the mPFC. d, Average of 64 recording mPFC sites showing that 
multiunit activity in the mPFC did not detectably increase following excitation of vmPFC 
terminals in the amygdala. Recordings with delivery of blue light to the vmPFC (a) or BMA 
(c) were obtained from the same mice. The 5 ms blue light pulse is shown in blue below the 
graph. A 32-site recording electrode probe was used to target deep cortical layers. n = 64 
sites from 2 animals (b, d). e–f, Compared to baseline controls (e), stimulation of ChR2-
expressing vmPFC fibres in the BMA of freely behaving awake animals (f) did not change 
c-Fos expression in deep layers of the vmPFC (layers 5 and 6). g, Summary bar graph 
showing the mean percentage of c-Fos positive cells in control animals and mice with 
stimulation of vmPFC fibres in the BMA. n = 5 animals for each group. e–f, Arrowheads 
indicate examples of c-Fos-expressing cells. Scale bar, 10 μm; error bars, ± s.e.m.; n refers 
to biological replicates.
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Extended Data Figure 5. vmPFC innervation of the amygdala in mice and rats
a, b, Mice were injected with AAV5-CamK2α -YFP in the vmPFC and fibres were imaged 
in the amygdala. a, Top, DAPI-stained amygdala section. Bottom, vmPFC fibres in the 
BMA 1.3 mm posterior from bregma. This coordinate was used for the fibre optic 
implantation in the vmPFC–amygdala behavioural cohorts. b, Same as a, but for a more 
posterior section (2.3 mm from bregma), showing no prominent vmPFC fibres of passage 
that traverse the BMA and terminate elsewhere. Nuclei were stained with DAPI, n = 4 mice. 
Scale bar, 0.5 mm. c, Rats were injected with AAV5-CaMK2α -SSFO-YFP in the vmPFC 
(infralimbic cortex). Six months following viral injection brain slices were stained for FoxP2 
to identify ITCs (red). The representative image shows vmPFC fibres (green) surrounding an 
ITC cluster (circled in white). Note that the vmPFC does not strongly innervate the ITCs in 
rats. Nevertheless, a sparse vmPFC–ITC projection can be seen. Image from one 
representative animal chosen from n = 3 rats. Scale bar, 100 μm. d, e, Mice were injected 
with AAV5-CamK2α -ChR2-YFP in the vmPFC. Fibre optics were placed above the 
amygdala (amy), but 500 μm posterior to the implants shown in Fig. 1. Delivery of blue light 
to this posterior amygdala site did not alter exploration of the open arms in the elevated plus 
maze (d) or freezing in cued fear conditioning (e), suggesting that activation of vmPFC 
fibres of passage that go beyond the amygdala do not have an important role in regulating 
anxiety and fear. n = 7 vmPFC–posterior amygdala:YFP and 8 vmPFC–posterior 
amygdala:ChR2 mice. Error bars, ± s.e.m.; n refers to biological replicates.
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Extended Data Figure 6. Quantification of BMA-projecting vmPFC neurons
a–c, Mice were injected with the retrogradely propagating ΔG rabies-GFP virus in the 
basomedial amygdala (BMA). a, Ten days after viral infusion, retrogradely labelled vmPFC 
cells can be seen expressing GFP. The number of GFP-expressing vmPFC cells was 
quantified across layers, both as a percentage of all GFP-positive cells (b) and as a 
percentage of all vmPFC cells (c) (counting labelled and unlab elled cells). n = 4 mice; scale 
bar, 75 μm (a). d, Mice were injected with retrobeads in the BMA. e, Image of a coronal 
section containing the mPFC. Note the presence of retrobead-containing cells in the vmPFC. 
f, Expanded image of the zone demarcated by a red rectangle in e. Labelled cells can be seen 
in the vmPFC, but not the dmPFC. g, h, Confocal image showing unlabelled cells in the 
dmPFC (g) and labelled cells in the vmPFC (h). a, g, h, Nuclei were stained with DAPI. n = 
5 mice (d–h). Scale bars, 250 μm (d); 500 μm (e, f); 10 μm (g, h). Error bars, ± s.e.m.; n 
refers to biological replicates.
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Extended Data Figure 7. Characterization of the vmPFC–BMA projection by optical stimulation 
of vmPFC terminals in vivo and in vitro
a, Example trace from one mouse showing responses in a BMA cell following a train of 5-
ms 10 Hz pulses in an acute brain slice with ChR2-expressing vmPFC terminals. These were 
the same parameters used for behavioural optogenetic experiments. b, Optogenetic 
stimulation of vmPFC fibres in the BMA in acute brain slices elicited both IPSCs (red) and 
EPSCs (blue), which had significantly different latencies. TTX abolished both IPSCs and 
EPSCs. 4-AP was added in the presence of TTX to rescue monosynaptic responses. Note 
that 4-AP rescued the EPSC, but not the IPSC. n = 7 cells from n = 2 mice. c, BMA 
multiunit recordings were obtained in awake behaving mice during optical stimulation of 
ChR2-expressing vmPFC terminals. Activation of vmPFC terminals dramatically increased 
firing rates in the BMA. The graph shown is an average of n = 14 multiunit recordings from 
n = 4 mice. d, A GAD2-Cre mouse was injected with AAV5-DIO-mCherry in the BMA. 
First panel shows antibody staining against GABA. Middle panel shows expression of 
mCherry in Cre-expressing cells. Last panel shows a merged photo of the first two panels. 
Note overlap of mCherry expression and GABA staining. Arrowheads show examples of 
double-labelled cells. n = 5 mice. e, Example traces from one mouse (chosen from n = 3 
mice) showing stimulation of ChR2-expressing vmPFC terminals in amygdala acute slices 
elicits responses in both GAD2 negative (putative excitatory projection cells) and positive 
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cells (inhibitory interneurons). Recordings were done in the presence of TTX and 4-AP to 
abolish polysynaptic responses. f, Scheme displaying the location of all recorded cells. 
Responsive cells are shown as filled circles. Inset shows a BMA cell being patched. Inset 
scale bar, 10 μm. g, Left: mean percentage of responsive cells. Middle: average response 
size of recorded cells. Right: Average latency of recorded responses relative to the start of 
the light pulse., n = 12 GAD2 positive and 12 GAD2 negative cells (from n = 3 mice) (e–g). 
4-AP, 4-aminopyridine; TTX, tetrodotoxin; IPSC, inhibitory postsynaptic current; EPSC, 
excitatory postsynaptic current. a, b, c, e, A 5 ms pulse of blue light (indicated by a blue tick 
mark) was used to elicit stimulation. *P < 0.05; error bars, ± s.e.m.; n refers to biological 
replicates.
Extended Data Figure 8. Activation of BMA-projecting vmPFC cells decreases cued fear
a, Mice were injected with the retrogradely propagating canine adenovirus encoding Cre 
recombinase (CAV-Cre) in the BMA. Mice were also injected with a viral vector that 
induces expression of ChR2-YFP or YFP only in the presence of Cre recombinase (AAV5-
DIO-ChR2-YFP). Mice were implanted bilaterally with fibre optics above the vmPFC for 
delivery of blue light. b–d, Delivery of blue light (10 Hz, 5-ms pulses at 10 mW) did not 
alter exploration of the open arms in the EPM (b), the centre of the open field (c), or speed 
(d). n = 7 vmPFC–amygdala:CAV-YFP and 8 vmPFC–amygdala:CAV-ChR2 mice. Error 
bars, ± s.e.m.; n refers to biological replicates.
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Extended Data Figure 9. BMA activity and function in anxiety and fear paradigms
a, Example isolated BMA single-unit spike clusters recorded with stereotrodes in vivo. b, 
Waveforms of the single-unit clusters shown in a, as recorded on each of the two electrodes 
comprising the stereotrode. c, Ratios of BMA neuron open arm/closed arm firing rates are 
shown for minutes 1 to 10 (epoch 1) and minutes 10 to 20 (epoch 2) of a 20 min exploration 
session of the elevated plus maze (EPM). Open/closed firing rate ratios are highly correlated 
across both epochs (r = 0.45, Spearman correlation), indicating that BMA firing patterns 
were stable throughout the entire 20 min session. d, The same cells shown in c were also 
recorded in the home cage and in the light/dark test. Firing rates in the light compartment of 
the light/dark test and the open arms of the EPM (plotted as fold-increase of rates from the 
non-anxiogenic home cage) were highly correlated (r = 0.65, Spearman correlation), 
indicating that BMA neurons respond similarly to anxiety induced by two different 
anxiogenic stimuli (bright lights and open areas). n = 38 cells from n = 4 mice (a–d). e–h, 
Recordings were obtained from basomedial amygdala (BMA) cells during presentation of a 
fear conditioned auditory tone. e, Top, distribution of responsive cells to the auditory tone 
before fear conditioning. Bottom, same as in upper panel, but for a fear recall test. The 
proportion of responsive cells increased following fear conditioning. Note that the vast 
majority of tone-responsive cells showed decreases in firing rate during the presentation of 
the fear-conditioned tone. f, Example cell that was not tone-responsive. g, h, Example cells 
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that are inhibited (g) or excited (h) during tone presentation. e, n = 20 cells during 
habituation and 71 cells during fear recall. f–h, Data are an average of ten tone presentations 
for each of the three cells shown. n = 4 mice (a–h). i, Mice were injected with AAV5-
CamK2α -NpHR-YFP in the BMA. i, j, Yellow light didn’t change behaviour in the 
elevated plus maze (i), or cued fear extinction (j). n = 8 BMA:NpHR and 7 BMA:YFP mice 
(i, j). k, Eight weeks after viral injections BMA projections can be seen in BMA:YFP mice 
in the anterodorsal bed nucleus of the stria terminalis (adBNST) but not in the oval BNST 
(ovBNST). l, Prominent BMA innervation was also visible in the infralimbic cortex (IL), but 
not in the prelimbic (PL), dorsal peduncular (DP) or cingulate cortices (Cg). Images from 
one representative mouse chosen from n = 9 BMA:YFP mice. Scale bars, 250 μm (a, b); 500 
μm (k, l). Error bars, ± s.e.m.; n refers to biological replicates.
Extended Data Table 1
Anxiety behavioural data in absolute values 
Figure location 0–5 min. 5–10 min. 10–15 min. 15–20 min.
vmPFC-amy:YFP EPM 1b 57±12 73±15 63±19
vmPFC-amy:ChR2 EPM 1b 63±14 50±11 61±14
dmPFC-amy:YFP EPM 1f 53±7 48±17 38±5
dmPFC-amy:ChR2 EPM 1f 50±12 46±16 42±17
BMA:YFP EPM 5j 64±14 35±11 31±14
BMA:ChR2 EPM 5j 65±19 77±23 45±19
BMA:YFP OFT 5l 62±9.6 84±13 91±17 122±23
BMA:NpHR OFT 5l 66±8.5 66±10 73±13 71±9.5
Table displaying time spent (in seconds) in the open arms of the elevated plus maze (EPM) or the centre of the open field 
test (OFT). Values are expressed as averages ± s.e.m.
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Figure 1. Activating vmPFC but not dmPFC terminals in amygdala decreases anxiety
a, vmPFC-amy:ChR2 mice expressing ChR2 in vmPFC with fibreoptics above amygdala. b, 
Blue light increased exploration of open arms in vmPFC-amy:ChR2 mice. n = 11 v mPFC–
amygdala:C hR2; 10 vmPFC–amygdala:YFP mice. c, Respiratory rates recorded for 5 min 
in home cage and 10 min in open field (red dashed rectangle). Blue light in vmPFC–
amygdala:ChR2 mice prevented increases in respiratory rate in open field (OFT) relative to 
home cage, without altering locomotion (d). n = 11 vmPFC–amygdala:ChR2; 6 vmPFC–
amygdala:YFP mice. e–h, Same as a–d, but for dmPFC–amygdala projections. n = 7 
dmPFC–amygdala:YFP; 7 mPFC–amygdala:ChR2 mice. i, vmPFC–amygdala:NpHR mice 
expressing eNpHR3.0 (abbreviated in all figures as NpHR) in vmPFC with fibre optics 
above amygdala. j, k, Yellow light decreased exploration of open arms (j; n = 8 vmPFC–
amygdala:NpHR; 7 vmPFC–amygdala:YFP) and increased home cage respiratory rates (k; n 
= 6 vmPFC-amygdala:NpHR; 6 vmPFC–amygdala:YFP). l, Yellow light did not alter 
overall locomotion (n = 14 vmPFC-amygdala:NpHR; 11 vmPFC–amygdala:YFP). m, 
vmPFC:NpHR mice with fibre optics above vmPFC. n–p, Yellow light did not change 
exploration of EPM (n), home cage respiratory rates (o) or speed (p). n = 11 vmPFC:NpHR; 
8 vmPFC:YFP mice. *P < 0.05; **P < 0.01, Two-sided Wilcoxon test. Data plotted in 5-min 
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consecutive intervals. Light delivery epochs labelled ON or with blue/yellow bars. Error 
bars, mean ± s.e.m.
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Figure 2. Activation of vmPFC–amygdala and dmPFC–amygdala projections: opposite effects 
on cued fear
a, Mice fear conditioned to four tone-shock pairings (0.4 mA/1-s shocks) on day 1; 
extinction on day 2. Blue light delivered on day 2; trials 2–11. dmPFC–amygdala:ChR2 
mice froze more than controls during day 3. n = 11 mPFC–amygdala:YFP, 7 vmPFC–
amygdala:ChR2, 13 dmPFC–amygdala:ChR2 mice. b, Same as a, but six tone-shock 
pairings (0.7 mA/2-s shocks). vmPFC–amygdala:ChR2 mice froze less than controls at end 
of extinction and during extinction retrieval. n = 12 mPFC–amygdala:YFP, 9 vmPFC–
amygdala:ChR2, 10 dmPFC–amygdala:ChR2 mice. c, Mice received five foot shocks (0.4 
mA/1-s shocks) during contextual fear acquisition. Light decreased freezing in vmPFC–
amygdala:ChR2 mice. n = 8 vmPFC–amygdala:YFP; 9 vmPFC–amygdala:ChR2 mice. d, 
Same as c, but dmPFC–amygdala mice (n = 8 dmPFC-amygdala:YFP; 8 dmPFC–
amygdala:ChR2 mice). e, f, Contextual fear conditioning: three shocks, 0.4 mA/1 s. 
Delivery of light during day 2 did not alter freezing in vmPFC–amygdala:ChR2 (e) or 
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dmPFC–amygdala:ChR2 (f) mice. e, n = 7 vmPFC–amygdala:ChR2; 6 vmPFC–
amygdala:YFP mice. f, n = 7 dmPFC–amygdala:ChR2; 7 dmPFC–amygdala:YFP mice. g, 
h, Delivery of light during fear acquisition (0.7 mA/2-s shocks) did not alter freezing in 
vmPFC–amygdala:ChR2 (g) or dmPFC–amygdala:ChR2 (h) mice. g, h, n = 8, all cohorts; 
*P < 0.05, #P < 0.01; two-sided Wilcoxon test. Error bars, mean ± s.e.m.
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Figure 3. Basomedial amygdala: major target of vmPFC in amygdala
a, Left: location of amygdala nuclei. Right: lox-tdTomato reporter line crossed with EY266 
D1R∷Cre line for ITC visualization. Scale bar, 500 μm. b–d, AAV5-CamK2α∷ChR2-YFP 
injected in vmPFC; vmPFC fibres imaged in BLA (b), ITC (c) and BMA (d). a–d, 
Representative images from one mouse chosen out of n = 7 mice. e–g, Same as b–d, but for 
dmPFC. e–g, Representative images from one mouse chosen out of n = 7 mice. Scale bars, 
50 μm (c, f); 100 μm (b, e, d, g). h–l, c-Fos-expressing cells (red) counted in BMA (j), BLA 
(k) and ITCs (l) following vmPFC–amygdala activation; increased c-Fos can be seen in 
BMA of vmPFC–amygdala:ChR2 mice. n = 5 mice, for each group, 4 slices per mouse. m–
o, Rabies-ΔG-GFP injected in BMA (m); retrogradely labelled cells counted (n–o). n = 4 
mice (o). Scale bar, 500 μm (h, i, m, n). *P < 0.05, **P < 0.01, two-sided Wilcoxon test. 
Error bars, mean ± s.e.m.
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Figure 4. Functional connectivity: mPFC inputs to amygdala
a, Example traces from one mouse showing stimulation of ChR2-expressing vmPFC 
terminals in amygdala (acute slice) elicited responses in BMA, but not BLA or ITCs. 
Recordings in TTX and 4-AP to abolish polysynaptic responses. b, Locations of recorded 
cells. Inset: responsive biocytin-filled BMA cell. dITC, vITC and mITC: dorsal, ventral and 
main ITC clusters. n = 11 BMA, 8 BLA and 19 ITC cells. c, Mean percentage of responsive 
cells and response sizes. n = 4 mice (a–c). d–f, Same as a–c, but dmPFC terminal 
stimulation. n = 4 mice (d–f). b, e, Inset scale bar, 250 μm. Error bars, mean ± s.e.m.
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Figure 5. BMA cells encode anxiety-related contextual features, decrease anxiety and decrease 
freezing
a, CAV-Cre in BMA and AAV5-DIO-ChR2 in vmPFC. b, YFP-expression in BMA-
projecting vmPFC neurons. Scale bar, 75 μm. c, Light-decreased freezing. b, c, n = 7 
vmPFC–amygdala:CAV-YFP, 8 vmPFC–amygdala:CAV-ChR2. d, Heat maps of 
representative cells preferentially firing in closed arms (left) or open arms (middle), or with 
no arm-type preference (right). e, EPM scores (strong encoding of arm-type) for BMA units 
versus simulated spike trains; n = 3 single-unit examples chosen from 38 BMA units 
recorded from n = 4 mice. f, Distribution of open- and closed-arm-preferring cells (EPM 
score > 0) versus no task-related firing (EPM score ≤ 0). g, Average EPM scores. d–g, n = 
38 BMA single units from n = 4 mice. h, i, BMA:ChR2 mice expressing ChR2 in BMA 
with fibre optics above BMA. Scale bar, 1 mm. j, k, BMA activation increased open-arm 
exploration (j) and decreased freezing (k). i, j, n = 8 BMA:ChR2; 9 BMA:YFP. k, n = 6 
BMA:ChR2; 7 BMA:YFP. l, Delivery of light increased OFT centre-avoidance in 
BMA:NpHR mice. n = 8 BMA:NpHR; 7 BMA:YFP; *P < 0.05, **P < 0.01, two-sided 
Wilcoxon test. Error bars, mean ± s.e.m.
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Figure 6. vmPFC-BMA projection reverses anxiogenic effect of corticosterone
a, Chronic corticosterone (CORT) treatment decreased open-arm exploration. n = 10 no-
pellet, 10 placebo pellet, 7 (12 mg kg−1) CORT, 8 (25 mg kg−1) CORT mice. b, vmPFC–
amygdala activation reversed effect of CORT. NS, not significant. n = 15 YFP placebo + 
light, 15 YFP CORT + light, 15 ChR2 CORT + light, 7 ChR2 CORT + no light, 8 ChR2 
placebo + no light; *P < 0.05, **P < 0.01, two-sided Wilcoxon test. Error bars, mean ± 
s.e.m.
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